MDM2 and neoplasm: The resulting top ranking gene was MDM2, a key oncogene in the p53 pathway with elevated expression in multiple tumor types37, and 11 out of 14 tumor types showed altered RNA editing at the 3′ UTR of MDM2, with a median of 5 sites per tumor type.